Plasma Donor RNA Probe Analysis for Viral Detection (e.g., Hepatitis, HIV)
This test checks for specific viral genetic material in your plasma using a molecular probe. It helps identify infections like hepatitis or HIV that may not show up in standard blood tests.
["Detects hidden viral infections that could affect your health over time."]
Key facts at a glance
- LOINC
- 75860-7
- Short code
- HAV RNA+B19 DNA Pnl Plas Donr NAA+probe
- Synonyms
- HAV RNA+B19 DNA Pnl Plas Donr NAA+probe
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- probe-amp-tar
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
What This Test Measures
The test uses a specialized probe to detect the presence of viral RNA fragments in your plasma. RNA is a molecule that viruses use to replicate and can be found in the blood if an infection is present, even if symptoms aren’t yet obvious.
Why It’s Ordered
Your healthcare provider may order this test if you have risk factors for viral infections (e.g., exposure to bloodborne pathogens, certain medical conditions, or symptoms like fatigue, fever, or unexplained liver issues). It’s also used in donor screening to ensure safety.
Sample Collection and Process
A blood sample is drawn from a vein, and plasma is separated for testing. The viral RNA is extracted from the plasma and analyzed using a probe-based technique, which detects even small amounts of viral genetic material.
What to Expect Before the Test
No special preparation is needed, but inform your provider about any medications or recent illnesses. Avoid alcohol or strenuous activity 24 hours before the draw.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
This test plays a critical role in diagnosing viral infections early, especially in asymptomatic individuals or those with vague symptoms. Early detection can guide treatment decisions, monitor donor safety, or prevent transmission in healthcare settings.
Short name
Viral RNA Screening Probe
Frequently asked questions
Why might my provider recommend this test?
What does a positive result mean?
Can I get this test at home?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy